Cartesian Therapeutics (RNAC)

• Market cap: $163M
• 1 day: -8.19%
• 5 days: -9.38%
• 1 month: -9.12%
• 3 months: -18.12%
• 6 months: -46.91%
• Year to date: -7.1%
• 1 year: -67.55%
• 5 years: -95.87%
• 10 years: -98.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Employees: 66